The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Open Access
- 27 January 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3), 2477
- https://doi.org/10.3390/ijms24032477
Abstract
Synucleinopathies are a set of devastating neurodegenerative diseases that share a pathologic accumulation of the protein α-synuclein (α-syn). This accumulation causes neuronal death resulting in irreversible dementia, deteriorating motor symptoms, and devastating cognitive decline. While the etiology of these conditions remains largely unknown, microglia, the resident immune cells of the central nervous system (CNS), have been consistently implicated in the pathogenesis of synucleinopathies. Microglia are generally believed to be neuroprotective in the early stages of α-syn accumulation and contribute to further neurodegeneration in chronic disease states. While the molecular mechanisms by which microglia achieve this role are still being investigated, here we highlight the major findings to date. In this review, we describe how structural varieties of inherently disordered α-syn result in varied microglial receptor-mediated interactions. We also summarize which microglial receptors enable cellular recognition and uptake of α-syn. Lastly, we review the downstream effects of α-syn processing within microglia, including spread to other brain regions resulting in neuroinflammation and neurodegeneration in chronic disease states. Understanding the mechanism of microglial interactions with α-syn is vital to conceptualizing molecular targets for novel therapeutic interventions. In addition, given the significant diversity in the pathophysiology of synucleinopathies, such molecular interactions are vital in gauging all potential pathways of neurodegeneration in the disease state.Funding Information
- Maryland Stem Cell Research Fund (R01NS099460, R21NS106407, R21NS101400, R01AG073291)
- CurePSP (658-2018-06)
- AFAR New Investigator Award in Alzheimer’s disease (R01NS107318, R01AG071820, RF1NS125592, K01AG056841, R21NS125559)
- Parkinson’s Foundation (PF-JFA-1933)
- Maryland Stem Cell Research Fund (2019-MSCRFD-4292)
This publication has 165 references indexed in Scilit:
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s diseaseMolecular Neurodegeneration, 2013
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- Exosomal cell-to-cell transmission of alpha synuclein oligomersMolecular Neurodegeneration, 2012
- Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmissionNeurobiology of Disease, 2011
- Direct Evidence of Coexisting Horseshoe and Extended Helix Conformations of Membrane‐Bound Alpha‐SynucleinChemphyschem, 2010
- Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal SurvivalJournal of Neuroscience, 2010
- Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicityGlia, 2008
- In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's diseaseNeurobiology of Disease, 2006
- Mutation E46K increases phospholipid binding and assembly into filaments of human α‐synucleinFEBS Letters, 2004
- NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively UnfoldedBiochemistry, 1996